Skip to content
by Legal Desire
10 February 2026

Latham Advises on Satellos’ US$50 Million Initial US Offering

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Nathan Ajiashvili Lead Latham & Watkins LLP Partner Capital Markets New York
Adam Gelardi Lead Latham & Watkins LLP Partner Capital Markets New York
KC Sands Latham & Watkins LLP Associate Capital Markets New York
Emma Gilmore Latham & Watkins LLP Associate Capital Markets New York
Molly Mitchell Latham & Watkins LLP Associate Capital Markets New York
Andrea Ramezan-Jackson Latham & Watkins LLP Partner tax Washington, D.C.
Tessa Young Latham & Watkins LLP Associate tax Washington, D.C.
Elizabeth Richards Latham & Watkins LLP Partner FDA regulatory Washington, D.C.
Evan Miller Latham & Watkins LLP Associate FDA regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner healthcare regulatory Bay Area
Eliot Choy Latham & Watkins LLP Counsel intellectual property New York
Arun Mohan Latham & Watkins LLP Associate intellectual property New York
Patrick Chew Latham & Watkins LLP Associate intellectual property New York

Stated terms

Stated value
USD 50m (US$50 Million)
What the figure measures
Issue size
Client
Latham & Watkins LLPUnderwriters
Counterparties
Satellos Bioscience Inc. (Issuer)